HTA in the European Union: osteoporosis screening without proof of benefit

16 September 2019 - For the first time, an IQWiG team is in charge of assessing health technology for the ...

Read more →

Medibank joins Nexus Hospitals joint replacement surgery trial guaranteeing zero out-of-pocket costs

23 August 2019 - Doctors, Nexus Hospitals and Medibank start innovative joint replacement trial. ...

Read more →

Updated procedure and submission guidelines for the CADTH Common Drug Review

22 August 2019 - The Procedure and Submission Guidelines for the CADTH Common Drug Review has been updated with the ...

Read more →

1 July Medicare rebate increases

1 July 2019 - The Australian Government is providing $187 million to increase patient rebates for 176 General Practitioners service items ...

Read more →

NICE to make changes to health technology evaluation

26 June 2019 - The Voluntary Scheme for Branded Medicines Pricing and Access, agreed by government and the ABPI in ...

Read more →

Publication of Stage 1 PBS process improvements – cost recovery administrative guidelines and forms

24 June 2019 - The Department of Health and Medicines Australia have been working since late 2017 to deliver on ...

Read more →

Delayed patient access to innovative medical technologies in South Korea: a lead-time analysis of reimbursement coverage determinations

20 June 2019 - Timely access to innovative medical technologies driven by accelerated patient access pathways can substantially improve the health ...

Read more →

Plan for Australians living with pain

17 June 2019 - Australians living with chronic pain would have access to up to 20 Medicare-funded services each year ...

Read more →

PBS process improvements webinar - information forum

31 May 2019 - The Department of Health will be hosting a webinar on 14 June 2019 to provide industry, ...

Read more →

Biosimilars no longer reviewed through the CADTH CDR and pCODR processes

23 May 2019 - When CADTH launched a new, streamlined biosimilar review process in February 2018, we committed to evaluating ...

Read more →

$32.6 million for breast cancer scans under Medicare

29 March 2019 - The Liberal National Government will invest $32.6 million so breast cancer patients have life-saving scans covered under ...

Read more →

Procedural update on submission of Type I variations to EMA in March, April and May 2019

26 February 2019 - EMA is encouraging marketing authorisation holders intending to submit Brexit-related Type IA and Type IB variations ...

Read more →

Establishing the effectiveness of procedural interventions: the limited role of randomised trials

18 December 2018 - Procedural interventions comprise a large and growing component of medical care. Patients, physicians, health care organisations, and ...

Read more →

Proposal to harmonise, streamline and transition the Cancer Drug Implementation Advisory Committee to CADTH

14 December 2018 - Providing customised implementation support to decision-makers at all levels of the health system is a key ...

Read more →

Half of all health fund members to lose cover for hip and knee replacements

6 September 2018 - Half of all health fund members will have to pay higher premiums and switch to top ...

Read more →